Charlie Banks
Co-Founder & Managing Director @ VentureSouth
Charlie Banks is a seed investor at VentureSouth focused on Software and Health Care. Charlie Banks is the Co-Founder & Managing Director at VentureSouth.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Charlie Banks invests in
Stages Charlie Banks invests in
Countries Charlie Banks invests in
Investment Focus
Industry
- Software 3 (43%)
- Health Care 2 (29%)
- SaaS 1 (14%)
- Wellness 1 (14%)
- 3D Technology 1 (14%)
Stage
- Seed 2 (29%)
- Angel 1 (14%)
- Series A 1 (14%)
- Funding Round 1 (14%)
- Venture - Series Unknown 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CADchat
|
CADchat provides a cloud-based digital workspace tailored for product, engineering, and manufacturing teams. The platform enables live collaboration on native 3D CAD files without requiring screen sharing or file conversion across formats. | Seed / Aug 01, 2024 | |
Darby
|
Darby offers a platform that serves as a digital vending machine for medical equipment and diagnostics. By using Darby's product, any virtual care delivery model can toggle into hybrid care - allowing remote clinicians to order last-mile tests and treatments for their patients at home instead of referring them to expensive sites of care likethe emergency department. | Venture - Series Unknown / Mar 29, 2023 | |
Healthycell
|
Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $1.5M / Dec 01, 2022 | |
|
Healthycell
|
Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $2M / Angel / Dec 01, 2022 | |
Sprockets
|
Sprockets’ sophisticated software evaluates potential hires based on the traits of a company’s best employees to determine the right candidate in just a few minutes. There is no guesswork, frustration, or the expense of high turnover. It’s not magic — it’s logic. | $10M / Series A / Mar 28, 2022 | |
|
Sprockets
|
Sprockets’ sophisticated software evaluates potential hires based on the traits of a company’s best employees to determine the right candidate in just a few minutes. There is no guesswork, frustration, or the expense of high turnover. It’s not magic — it’s logic. | $3.4M / Seed / Jan 11, 2021 | |
|
Sprockets
|
Sprockets’ sophisticated software evaluates potential hires based on the traits of a company’s best employees to determine the right candidate in just a few minutes. There is no guesswork, frustration, or the expense of high turnover. It’s not magic — it’s logic. | $750K / Seed / Dec 17, 2018 |
Co-Investors
About VentureSouth
VentureSouth is an early-stage venture firm that develops and manages angel investment groups and funds throughout the Southeast. Since our inception with the Upstate Carolina Angel Network in 2008, VentureSouth has grown to include more than 550 investors across a dozen angel groups and funds, making us one of the largest angel investmentorganizations in the United States. To date, VentureSouth has deployed over $80 million in more than 100 companies. Follow us to learn how we Make Money. Have Fun. Do Good.
VentureSouth Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Charlie Banks
Co-Founder & Managing Director
|
|||
Malay Shah
Director
|
|||
Paul Clark
Managing Director
|
|||
Dawson Racek
Venture Analyst
|
|||
Matthew Dunbar
Co-Founder and Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Charlie Banks invest in?
Charlie Banks invests primarily in Software, Health Care and SaaS startups, most often at Seed and Angel stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Charlie Banks last invest?
The most recent investment recorded for Charlie Banks closed in Aug 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
